Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
FDA Clearance
Amgen gets FDA approval for small cell lung cancer therapy
Amgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).
Featured
Artificial Intelligence
Backlog of unresolved medical diagnoses leads to new method for clinical exome reanalysis
Stock
T2 Biosystems to sell $8M in stock in private placement
Latest News
FDA issues warning for Cue Health COVID-19 tests
May 14, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Northwell Health Cancer Institute opens molecular diagnostics laboratory
May 13, 2024
Danaher launches collaboration with Johns Hopkins University on TBI diagnostics
May 9, 2024
Business Insights
FDA Clearance
Amgen gets FDA approval for small cell lung cancer therapy
Regulatory Approval
Karius gets FDA breakthrough device designation for infectious disease test
Kickback
Clinical lab to pay $2.5M for rent sham kickback scheme
Emerging Technology
BioMarin confirms layoffs and R&D cuts
Diagnostic Technologies
Artificial Intelligence
Backlog of unresolved medical diagnoses leads to new method for clinical exome reanalysis
Trends and Finance
Northwell Health Cancer Institute opens molecular diagnostics laboratory
FDA Clearance
Qiagen gets FDA clearance for respiratory syndromic testing panel
PCR
Qiagen partners with FBI on forensics assay
Diseases
Emerging Technology
BioMarin confirms layoffs and R&D cuts
FDA Warning Letter
FDA issues warning for Cue Health COVID-19 tests
Emerging Technology
Biomarker extraction through ultrasound shows promise for cancer detection
Emergency Use Authorization
iHealth gets EUA for combination COVID-19/influenza at-home test
More from LabPulse.com
Novo Nordisk Foundation, Wellcome, Gates Foundation to partner on global health challenges
By
LabPulse.com staff writers
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a collaboration to support scientific research and development for accessible solutions to global health challenges.
May 6, 2024
FDA said no to proficiency testing for LDT quality
By
Liz Carey
Inferior tests can pass through proficiency testing, among ways PT falls short for test safety and effectiveness for intended purposes.
May 2, 2024
Cue Health to cut 230 jobs in restructuring plan
By
LabPulse.com staff writers
In a filing with the U.S. Securities and Exchange Commission, Cue Health said it intends to cut 230 jobs, 49% of its workforce, as part of a cost-reduction plan the firm is implementing.
May 3, 2024
Leica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology system
By
LabPulse.com staff writers
Leica Biosystems has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Aperio GT 450 DX digital pathology system, in conjunction with Sectra's digital pathology software.
May 2, 2024
Quest Diagnostics to add digital pathology lab, AI pathology center in Tennessee
By
LabPulse.com staff writers
Quest Diagnostics said it will acquire PathAI Diagnostics in Memphis, TN, the business of PathAI that provides anatomic and digital pathology laboratory services, to accelerate the adoption of digital and AI pathology.
May 1, 2024
Astellas and Poseida to collaborate on oncology cell therapies
By
LabPulse.com staff writers
Poseida Therapeutics and Astellas, under its Xyphos Biosciences subsidiary, have initiated a research collaboration and licensing agreement to develop allogeneic cell therapy programs by combining their innovative cell therapy platforms and technologies.
May 2, 2024
FDA releases LDT final rule
By
Liz Carey
The FDA announced its final rule on regulating laboratory developed tests (LDTs), also saying it will adopt targeted enforcement discretion for several categories of IVD LDTs manufactured by labs.
April 29, 2024
GSK, Genomics PLC collaborate on polygenic risk score use for clinical trials
By
LabPulse.com staff writers
Genomics PLC and biopharmaceutical firm GSK have established a collaboration aimed at assessing the potential for using polygenic risk scores in clinical trials.
May 1, 2024
Variantyx raises $36M in funding
By
LabPulse.com staff writers
Precision molecular diagnostics firm Variantyx has raised $36 million in a recent funding round, bringing the total funding that Variantyx has raised to more than $125 million.
April 30, 2024
Study: Age-related differences in nasal cells offer COVID-19 protection
By
Matt Limb
Key differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus may explain why children typically experience milder symptoms of COVID-19, say researchers.
April 29, 2024
Pillar Biosciences gets FDA approval for NGS solid tumor profiling test
By
Matt Limb
Pillar Biosciences has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its OncoReveal CDx pan-cancer next-generation sequencing (NGS) test for general solid tumor profiling.
April 26, 2024
Immunovia announces positive results for next-gen pancreatic cancer test
By
LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024